Composition
- Active ingredients
- NEVIRAPINE 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NEVIRAPINE 200MG · TabletANDA077429-001 · Tentative approval
- NEVIRAPINE 50MG/5ML · SuspensionANDA077702-001 · Prescription
- NEVIRAPINE 200MG · TabletANDA077956-001 · Prescription
- NEVIRAPINE 200MG · TabletANDA078644-001 · Discontinued
- NEVIRAPINE 200MG · TabletANDA078887-001 · Tentative approval
- NEVIRAPINE 200MG · TabletANDA202523-001 · Prescription
- NEVIRAPINE 400MG · Tablet, extended releaseANDA205258-001 · Discontinued
- NEVIRAPINE 100MG · Tablet, extended releaseANDA206271-001 · Discontinued
- NEVIRAPINE 400MG · Tablet, extended releaseANDA205921-001 · Tentative approval
- NEVIRAPINE 400MG · Tablet, extended releaseANDA207698-001 · Discontinued
- NEVIRAPINE 200MG · TabletANDA203021-001 · Discontinued
- NEVIRAPINE 200MG · TabletANDA203080-001 · Prescription
- NEVIRAPINE 400MG · Tablet, extended releaseANDA207064-001 · Tentative approval
At a glance
- Brand name
- Nevirapine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Pharmobedient
- Status
- Discontinued
- FDA approval
- 22 May 2012
- Application
- ANDA078864-001